Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Medicenna Therapeutics Corp (MDNAF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5387 +13.55%
on 03/07/19
0.6555 -6.68%
on 02/28/19
-0.0253 (-3.97%)
since 02/13/19
3-Month
0.5182 +18.04%
on 12/31/18
0.9098 -32.77%
on 12/14/18
-0.3363 (-35.47%)
since 12/13/18
52-Week
0.5182 +18.04%
on 12/31/18
1.6800 -63.59%
on 03/14/18
-1.0683 (-63.59%)
since 03/13/18

Most Recent Stories

More News
Medicenna Reports Third Quarter Fiscal 2019 Financial Results

TORONTO and HOUSTON, TX , Feb. 14, 2019  /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, today...

MDNAF : 0.6117 (+13.55%)
MDNA.TO : 0.82 (+7.89%)
Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55

Strong interim survival trend (15.2 vs 8.5 months) emerging in IL4R positive patients

MDNAF : 0.6117 (+13.55%)
MDNA.TO : 0.82 (+7.89%)
Medicenna Shows Promising Pre-Clinical Results in Solid Tumor Models with its IL-2 Superkine, MDNA109

Magnified IL-2 affinity towards CD122 potently synergizes with checkpoint inhibitors

MDNAF : 0.6117 (+13.55%)
MDNA.TO : 0.82 (+7.89%)
Preliminary Results on MDNA55 and MDNA109 to be Presented at the Immuno-Oncology 360° Conference

TORONTO and HOUSTON , Jan. 24, 2019 /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced...

MDNAF : 0.6117 (+13.55%)
MDNA.TO : 0.82 (+7.89%)
Medicenna to Present at Bloom Burton & Co. Healthcare Investor Conference 2018

TORONTO and HOUSTON , April 25, 2018 /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQX: MDNAF), a clinical stage immuno-oncology company, is pleased...

MDNAF : 0.6117 (+13.55%)
MDNA.TO : 0.82 (+7.89%)
Trade MDNAF with:

Key Turning Points

2nd Resistance Point 0.6117
1st Resistance Point 0.6117
Last Price 0.6117
1st Support Level 0.6117
2nd Support Level 0.6117

See More

52-Week High 1.6800
Fibonacci 61.8% 1.2362
Fibonacci 50% 1.0991
Fibonacci 38.2% 0.9620
Last Price 0.6117
52-Week Low 0.5182

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar